Quantitative systems pharmacology model of the amyloid pathway in Alzheimer's disease: Insights into the therapeutic mechanisms of clinical candidates-Reference-Cited by-同舟云学术

Quantitative systems pharmacology model of the amyloid pathway in Alzheimer's disease: Insights into the therapeutic mechanisms of clinical candidates

Published:2022-11-06 Issue:1 Volume:12 Page:62-73
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacom & Syst Pharma

Author:

Ramakrishnan Vidya¹^ORCID,Friedrich Christina²,Witt Colleen²,Sheehan Robert²,Pryor Meghan²,Atwal Jasvinder K.¹,Wildsmith Kristin¹,Kudrycki Katherine²,Lee Seung‐Hye¹,Mazer Norman³,Hofmann Carsten³,Fuji Reina N.¹,Jin Jin Y.¹^ORCID,Ramanujan Saroja¹,Dolton Michael⁴,Quartino Angelica¹

Affiliation:

1. Genentech, Inc. South San Francisco California USA

2. Rosa & Co., LLC. San Carlos California USA

3. F. Hoffmann‐La Roche Ltd Basel Switzerland

4. Roche Products Australia Pty Ltd New South Wales Sydney Australia

Publisher

Wiley

Subject

Pharmacology (medical),Modeling and Simulation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.12876

Reference50 articles.

1. 2021 Alzheimer's disease facts and figures

2. Mild Cognitive Impairment;Petersen RC;Continuum (Minneap Minn),2016

3. Clinical trials of new drugs for Alzheimer disease

4. Why do trials for Alzheimer’s disease drugs keep failing? A discontinued drug perspective for 2010-2015

5. FDA.FDA Grants Accelerated Approval for Alzheimer's Drug.https://www.fda.gov/news‐events/press‐announcements/fda‐grants‐accelerated‐approval‐alzheimers‐drug. Accessed January 18 2022.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Passive Immunotherapies Targeting Amyloid-βin Alzheimer’s Disease: A Quantitative Systems Pharmacology Perspective;Molecular Pharmacology;2023-10-31

2. Analysis of clinical failure of anti-tau and anti-synuclein antibodies in neurodegeneration using a quantitative systems pharmacology model;Scientific Reports;2023-09-01

3. Computational neurosciences and quantitative systems pharmacology: a powerful combination for supporting drug development in neurodegenerative diseases;Journal of Pharmacokinetics and Pharmacodynamics;2023-07-28

4. Clinical failure of anti-tau and anti-synuclein antibodies in neurodegeneration: a quantitative systems pharmacology model analysis;2023-05-02